Paul Marks to Head Search Committee For National Cancer Institute Director

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 3
Volume 4
Issue 3

WASHINGTON--HHS Secretary Donna Shalala has appointed Paul Marks, president, Memorial Sloan-Kettering Cancer Institute, to chair the search committee for a director of the National Cancer Institute, to replace Dr. Samuel Broder, who now plans to leave in March instead of April as originally announced.

WASHINGTON--HHS Secretary Donna Shalala has appointed Paul Marks,president, Memorial Sloan-Kettering Cancer Institute, to chairthe search committee for a director of the National Cancer Institute,to replace Dr. Samuel Broder, who now plans to leave in Marchinstead of April as originally announced.

The 14-member committee (twice as large as the one convened tofind a replacement for Vincent DeVita) is expected to make itsrecommendations to the White House by March 15.

Other committee members are Frances Visco, JD, National BreastCancer Coalition; Karen Antman, Columbia University; FernandoCabanillas, M.D. Anderson; Anthony Fauci, National Institute ofAllergy and Infectious Diseases; Harold Freeman, chairman, President'sCancer Panel; Maxine Singer, Carnegie Institute; and Eli Glatsteinand Joseph Goldstein, University of Texas Southwestern MedicalCenter.

Also, Kenneth Olden, National Institute of Environmental HealthSciences; Shirley Tilghman, Howard Hughes Medical Institute; ChristopherWalsh, Dana-Farber; Samuel Wells, Washington University; and CharlesWilson, University of California, San Francisco.

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content